Development of T2DM in mother ‐ not reported · women with gestational diabetes mellitus and their babies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Large‐for‐gestational age · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes large‐for‐gestational age compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Shoulder dystocia · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes shoulder dystocia compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Health status and well‐being – neonatal morbidity and mortality combined · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes composite outcome neonatal morbidity or mortality compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Neonatal hypoglycaemia · women with gestational diabetes mellitus and their babies
Fetal biometry showed no clear difference in neonatal hypoglycaemia compared with maternal glycaemic values (low certainty).
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes perinatal mortality compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Stone clearance · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers may leads to higher stone clearance compared with standard therapy (low certainty).
1 finding from 1 review
Stone expulsion time · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Pain episodes · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Dose of diclofenac (mg) · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Hospital admissions · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in hospitalisation compared with placebo (moderate certainty).
1 finding from 1 review
Surgical intervention · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in surgical intervention compared with placebo (high certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in major adverse events compared with standard therapy (low certainty).
1 finding from 1 review
Stone expulsion time · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Pain episodes · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Dose of diclofenac · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Hospital admissions · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to lower hospitalisation compared with standard therapy (moderate certainty).
1 finding from 1 review
Surgical intervention · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in surgical intervention compared with standard therapy (low certainty).
1 finding from 1 review
Stone clearance · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher stone clearance compared with placebo (moderate certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher major adverse events compared with placebo (moderate certainty).
1 finding from 1 review